Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-12T05:32:41.830Z Has data issue: false hasContentIssue false

Section 4 - Vascular Conditions of the Eyes, Ears, and Brain

Published online by Cambridge University Press:  15 June 2018

Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Uncommon Causes of Stroke , pp. 273 - 304
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Biswas, J., Sharma, T., Gopal, L., et al. 2002. Eales disease: An update. Surv Ophthalmol, 47, 197–214.Google Scholar
Cai, S. J., Su, G., Li, H., et al. 2013. Profiling of human leukocyte antigens in Eales disease and tuberculosis. Int Ophthalmol, 33, 475–9.CrossRefGoogle ScholarPubMed
Chang, T. S., Aylward, G. W., Davis, J. L., et al. 1995. The retinal vasculitis study group. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Ophthalmology, 102, 1089–97.Google Scholar
Das, T., Pathengay, A., Hussain, N., et al. 2010. Eales’ disease: Diagnosis and management. Eye (Lond), 24, 472–82.Google Scholar
Dastur, D. K. and Singhal, B. S. 1976. Eales’ disease with neurological involvement. Part 2. Pathology and pathogenesis. J Neurol Sci, 27, 323–45.CrossRefGoogle ScholarPubMed
Dehghan, M. H., Ahmadieh, H., Soheilian, M., et al. 2005. Therapeutic effects of laser photocoagulation and/or vitrectomy in Eales’ disease. Eur J Ophthalmol, 15, 379–83.CrossRefGoogle ScholarPubMed
Duker, J. S., Brown, G. C., and McNamara, J. A. 1988. Proliferative sarcoid retinopathy. Ophthalmology, 95, 1680–6.CrossRefGoogle ScholarPubMed
Goldberg, M. F. 1971. Natural history of untreated proliferative sickle retinopathy. Arch Opthalmol, 85, 428–37.Google Scholar
Hammond, M. D., Ward, T. P, Katz, B., et al. 2004. Elevated intracranial pressure associated with idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. J Neuroophthalmol, 24, 221–4.Google Scholar
Karam, E. Z., Muci-Mendoza, R., and Hedges, T. R. III. 1999. Retinal findings in Takayasu’s arteritis. Acta Ophthalmol Scand, 77, 209–13.Google Scholar
Mizener, J. B., Podhajsky, P., and Hayreh, S. S. 1997. Ocular ischemic syndrome. Ophthalmology, 104, 859–64.Google Scholar
O’Halloran, H. S., Pearson, P. A., Lee, W. B., et al. 1998. Microangiopathy of the brain, retina and cochlea (Susac syndrome). Ophthalmology, 105, 1038–44.Google ScholarPubMed
Singh, R., Toor, P., Parchand, S., et al. 2012. Quantitative polymerase chain reaction for Mycobacterium tuberculosis in so-called Eales’ disease. Ocul Immunol Inflamm, 20, 153–7.Google Scholar

References

Abu-Yaghi, N. E, Hartono, S. P., Hodge, D. O., Pulido, J. S., and Bakri, S. J. 2011. White dot syndromes: A 20-year study of incidence, clinical features, and outcomes. Ocul Immunol Inflamm, 19, 426–30.CrossRefGoogle ScholarPubMed
Al Kawi, A., Wang, D. Z., Kishore, K., and Kattah, J. C. 2004. A case of ischemic cerebral infarction associated with acute posterior multifocal placoid pigment epitheliopathy, CNS vasculitis, vitamin B (12) deficiency and homocysteinemia. Cerebrovasc Dis, 18, 338–9.CrossRefGoogle ScholarPubMed
Althaus, C., Unsold, R., Figge, C., and Sundmacher, R. 1993. Cerebral complications in acute posterior multifocal placoid pigment epitheliopathy. Ger J Ophthalmol, 2, 150–4.Google Scholar
Anderson, K., Patel, K. R., Webb, L., and Dutton, G. N. 1996. Acute posterior multifocal placoid pigment epitheliopathy associated with pulmonary tuberculosis (letter). Br J Ophthalmol, 80, 186.Google Scholar
Annesley, W. H., Tomer, T. L., and Shields, J. A. 1973. Multifocal placoid pigment epitheliopathy. Am J Ophthalmol, 76, 511–8.Google Scholar
Azar, P., Gohd, R. S., Waltman, D., and Gitter, K. A. 1975. Acute posterior multifocal placoid pigment epitheliopathy associated with adenovirus type 5 infection. Am J Ophthalmol, 80, 1003–5.Google Scholar
Bewermeyer, H., Nelles, G., Huber, M., et al. 1993. Pontine infarction in acute posterior multifocal placoid pigment epitheliopathy. J Neurol, 241, 22–6.Google Scholar
Biswas, J., Raghavendran, R., Pinakin, G., and Arjundas, D. 2001. Presumed Eales’ disease with neurologic involvement: Report of three cases. Retina, 21, 141–5.CrossRefGoogle ScholarPubMed
Bodiguel, E., Benhamou, A., Le Hoang, P., and Gautier, J. C. 1992. Infarctus cérébral, épithéliopathie en plaques et sarcoïdose. Rev Neurol (Paris), 148, 746–51.Google Scholar
Bodine, S. R., Marino, J., Camisa, T. J., and Salvate, A. J. 1992. Multifocal choroiditis with evidence of Lyme disease. Ann Ophthalmol, 24, 169–73.Google ScholarPubMed
Borruat, F. X., Piguet, B., and Herbort, C. P. 1998. Acute posterior multifocal placoid pigment epitheliopathy following mumps. Ocul Immunol Inflamm, 6, 189–93.Google Scholar
Brazis, P. W., Stewart, M., and Lee, A. G. 2004. The uveo-meningeal syndromes. Neurologist, 10, 171–84.Google Scholar
Brézin, A. P., Massin-Korobelnik, P., Boudin, M., Gaudric, A., and LeHoang, P. 1995. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol, 113, 297–300.Google Scholar
Bridges, W. J., Saadeh, C., and Gerald, R. 1995. Acute posterior multifocal placoid pigment epitheliopathy in a patient with systemic-onset juvenile rheumatoid arthritis: Treatment with cyclosporin A and prednisone. Arthritis Rheum, 38, 446–7.Google Scholar
Brown, M., Eberdt, A., and Ladas, G. 1973. Pigment epitheliopathy in a patient with mycobacterium infection. J Ped Ophthalmol, 10, 278–81.Google Scholar
Bugnone, A. N., Hartker, F., Shapiro, M., Pineless, H. S., and Velez, G. 2006. Acute and chronic brain infarcts on MR imaging in a 20-year-old woman with acute posterior multifocal placoid pigment epitheliopathy. AJNR Am J Neuroradiol, 27, 67–9.Google Scholar
Bullock, J. D. and Fletcher, R. L. 1977. Cerebrospinal fluid abnormalities in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol, 84, 45–9.CrossRefGoogle Scholar
Caccavale, A. and Mignemi, L. 2001. Fluorescein and indocyanine green angiography findings in a case of poststreptococcal syndrome with erythema nodosum and posterior uveitis. Retina, 21, 669–72.Google Scholar
Case, D., Seinfeld, J., Kumpe, D., et al. 2015. Acute posterior multifocal placoid pigment epitheliopathy associated with stroke: A case report and review of the literature. J Stroke Cerebrovasc Dis, 24, e295–302.CrossRefGoogle ScholarPubMed
Castro, P., Costa, A., Abreu, P., et al. 2016. Acute posterior multifocal placoid pigment epitheliopathy presenting with multiple brain and spinal cord infarctions. J Neurol Sci, 361, 26–8.Google Scholar
Chiquet, C., Lumbroso, L., Denis, P., et al. 1999. Acute posterior multifocal placoid pigment epitheliopathy associated with Wegener’s granulomatosis. Retina, 19, 309–13.CrossRefGoogle ScholarPubMed
Clearkin, L. G. and Hung, S. O. 1983. Acute posterior multifocal placoid pigment epitheliopathy associated with transient hearing loss. Trans Ophthalmol Soc UK, 103, 562–4.Google ScholarPubMed
Comu, S., Verstraeten, T., Rinkoff, J. S., and Busis, N. A. 1996. Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke, 27, 996–1001.Google Scholar
del Saz-Saucedo, P., Alfaya-Muñoz, L. B., Recio-Bermejo, M., et al. 2013. Acute posterior multifocal placoid pigment epitheliopathy. A rare cause of ischaemic stroke. Rev Neurol 56, 567–72. Review. Spanish.Google Scholar
de Vries, J. J., den Dunnen, W. F., Timmerman, E. A., Kruithof, I. G., and De Keyser, J. 2006. Acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis: A multisystem granulomatous disease. Arch Ophthalmol, 124, 910–3.Google Scholar
Deutman, A. F., Oosterhuis, J. A., Boen-Tan, T. N., and Aan De Kerk, A. L. 1972. Acute posterior multifocal placoid pigment epitheliopathy. Pigment epitheliopathy or choriocapillaritis. Br J Ophthalmol, 56, 863–74.Google Scholar
Dhaliwal, R. S., Maguire, A. M., Flower, R. W., and Arribas, N. P. 1993. Acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiographic study. Retina, 13, 317–25.Google Scholar
Di Crecchio, L., Parodi, M. B., Saviano, S., and Ravalico, G. 2001. Acute posterior multifocal placoid pigment epitheliopathy and ulcerative colitis: A possible association. Acta Ophthalmol Scand, 79, 319–21.Google Scholar
Dick, D. J., Newman, P. K., Richardson, J., Wilkinson, R., and Morley, A. R. 1988. Acute posterior multifocal placoid pigment epitheliopathy and sarcoidosis. Br J Ophthalmol, 72, 74–7.Google Scholar
Dickinson, A. J., Rosenthal, A. R., and Nicholson, K. G. 1990. Inflammation of the retinal pigment epithelium: A unique presentation of ocular schistosomiasis. Br J Ophthalmol, 74, 440–2.Google Scholar
El Sanhouri, A., Sisk, R. A., and Petersen, M. R. 2012. Mortality from cerebral vasculitis associated with rapid steroid taper during treatment of acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol, 130, 935–7.Google Scholar
Engelinus, F., Rasquin, F., Blecic, S., and Zanen, A. 1999. Placoid pigment epitheliopathy and cerebral vasculitis: A clinical case. Bull Soc Belge Ophthalmol, 274, 41–6.Google Scholar
Ferro, J. M. 1998. Vasculitis of the central nervous system. J Neurol, 245, 766–76.Google Scholar
Fishman, G. A., Baskin, M., and Jednock, N. 1977. Spinal fluid pleocytosis in acute posterior multifocal placoid pigment epitheliopathy. Ann Ophthalmol, 9, 36.Google Scholar
Foulds, W. S. and Damato, B. E. 1986. Investigations and prognosis in the retinal pigment epitheliopathies. Aust N Z J Ophthalmol, 14, 301–11.CrossRefGoogle ScholarPubMed
Frohman, L. P., Klug, R., Bielory, L., Patti, J. C., and Noble, K. G. 1987. Acute posterior multifocal placoid pigment epitheliopathy with unilateral retinal lesions and bilateral disk edema. Am J Ophthalmol, 104, 548–50.CrossRefGoogle ScholarPubMed
Furusho, F., Imaizumi, H., and Takeda, M. 2001. One case of Harada disease complicated by acute posterior multifocal placoid pigment epitheliopathy-like recurrence in both eyes. Jpn J Ophthalmol, 45, 117–8.Google Scholar
Gass, J. D. M. 1968. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol, 80, 177–85.CrossRefGoogle ScholarPubMed
Gass, J. D. M. 1983. Acute posterior multifocal placoid pigment epitheliopathy: A long-term follow up. In Management of Retinal Vascular and Macular Disorder, eds. Fine, S. L., and Owens, L.. Baltimore, MD: Williams and Wilkins Co., pp. 176–81.Google Scholar
Gass, J. D. 1993. Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992. J Clin Neuroophthalmol, 13, 79–97.Google Scholar
Gass, J. D. 2000. The acute zonal outer retinopathies. Am J Ophthalmol, 130, 655–7.Google Scholar
Gass, J. D. 2003. Are acute zonal occult outer retinopathy and the white spot syndromes (AZOOR complex) specific autoimmune diseases? Am J Ophthalmol, 135, 380–1.CrossRefGoogle ScholarPubMed
Gass, J. D., Braunstein, R. A., and Chenoweth, R. G. 1990. Acute syphilitic posterior placoid chorioretinitis. Ophthalmology, 97, 1288–97.Google Scholar
Gibelalde, A., Bidaguren, A., Ostolaza, J. I., Cortazar, L., and Irigoyen, C. (2009) Pigmentary epitheliopathy multifocal acute placoid associated with paralysis of VI cranial par. Arch Soc Esp Oftalmol, 84, 159–162.Google Scholar
Gordon, M. F., Coyle, P. K., and Golub, B. 1988. Eales’ disease presenting as stroke in the young adult. Ann Neurol, 24, 264–6.Google Scholar
Hammer, M. E., Grizzard, W. S., and Travies, D. 1989. Death associated with acute multifocal placoid pigment epitheliopathy. Arch Ophthalmol, 107, 170–1.Google Scholar
Hector, R. E. 1978. Acute posterior multifocal posterior pigment epitheliopathy. Am J Ophthalmol, 86, 424–5.CrossRefGoogle Scholar
Hedges, T. R., Sinclair, S. H., and Gragoudas, E. S. 1979. Evidence for vasculitis in acute posterior multifocal placoid pigment epitheliopathy. Ann Ophthalmol, 11, 539–42.Google Scholar
Holt, W. S., Regan, C. D. J., and Trempe, C. 1976. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol, 81, 403–12.Google Scholar
Howe, L. J., Woon, H., Graham, E. M., et al. 1995. Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. Ophthalmology, 102, 790–8.Google Scholar
Hsu, C. T., Harlan, J. B., Goldberg, M. F., and Dunn, J. P. 2003. Acute posterior multi-focal placoid pigment epitheliopathy associated with a systemic necrotizing vasculitis. Retina, 23, 64–8.CrossRefGoogle Scholar
Jacklin, H. N. 1977. Acute posterior multifocal placoid pigment epitheliopathy and thyroiditis. Arch Ophthalmol, 95, 995–7.Google Scholar
Jampol, L. M. and Becker, K. G. 2003. White spot syndromes of the retina: A hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol, 135, 376–9.Google Scholar
Jaramillo, A., Gaete, G., Romero, P., Orellana, P., and Illanes, S. 2009. Acute pontine infarct in a 16-year-old man with acute posterior multifocal placoid pigment epitheliopathy. A case report. J Stroke Cerebrovasc Dis, 18, 164–6.Google Scholar
Jenkins, R. B., Savino, P. J., and Pilkerton, A. R. 1973. Placoid pigment epitheliopathy with swelling of the optic disks. Arch Neurol, 29, 204–5.Google Scholar
Jimenez, P. E., Marsal, C., Velazquez, J. M., and Alvarez, A. 2003. Eales’ disease with bilateral brain strokes and jaw-closing dystonia. Neurologia, 18, 750–3.Google Scholar
Jones, N. P. 1995. Acute posterior multifocal placoid pigment epitheliopathy. Br J Ophthalmol, 79, 384–9.CrossRefGoogle ScholarPubMed
Joswig, H., Flueckiger, C., Infanger, A., Tettenborn, B., and Felbecker, A. 2011. Recurring meningoencephalitis in sinusitis-associated acute posterior multifocal placoid pigment epitheliopathy under prednisone tapering. BMJ Case Rep, doi: 10.1136/bcr.02.2011.3820.Google Scholar
Katz, B., Wheeler, D., Weinreb, R. N., and Swenson, M. R. 1991. Eales’ disease with central nervous system infarction. Ann Ophthalmol, 23, 460–3.Google Scholar
Kawaguchi, Y., Hara, M., Hirose, T., et al. 1990. A case of SLE complicated with multifocal posterior pigment epitheliopathy. Ryumachi, 30, 396–402.Google Scholar
Kersten, D. H., Lessell, S., and Carlow, T. J. 1987. Acute posterior multifocal placoid pigment epitheliopathy and late-onset meningo-encephalitis. Ophthalmology, 94, 393–6.CrossRefGoogle ScholarPubMed
Kim, R. Y., Holz, F. G., Gregor, Z., and Bird, A. C. 1995. Recurrent acute multifocal placoid pigment epitheliopathy in two cousins. Am J Ophthalmol, 119, 660–2.Google Scholar
Kirkham, T. H., Ffytche, T. J., and Sanders, M. D. 1972. Placoid pigment epitheliopathy with retinal vasculitis and papillitis. Br J Ophthalmol, 56, 875–80.Google Scholar
Kumaravelu, S., Johri, S., Mukherji, J. D., Poduval, R. G., and Bhandari, N. K. 2002. Eales’ disease with neurological manifestations. J Assoc Physicians India, 50, 596–8.Google Scholar
Laatikainen, L. T. and Immonen, I. J. 1988. Acute posterior multifocal placoid pigment epitheliopathy in connection with acute nephritis. Retina, 8, 122–4.CrossRefGoogle ScholarPubMed
Lie, J. T. 1997. Classification and histopathologic spectrum of central nervous system vasculitis. Neurol Clin, 15, 805–19.Google Scholar
Lowder, C. Y., Foster, R. E., Gordon, S. M., and Gutman, F. A. 1996. Acute posterior multifocal placoid pigment epitheliopathy after acute group A streptococcal infection. Am J Ophthalmol, 122, 115–7.Google Scholar
Luneau, K., Newman, N. J., Srivastava, S., and Biousse, V. 2009. A case of acute posterior multifocal placoid pigment epitheliopathy with recurrent stroke. J Neuroophthalmol, 29, 111–18.Google Scholar
Lyness, A. L. and Bird, A. C. 1984. Recurrences of acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol, 98, 203–7.Google Scholar
Mafrici, M., Salomone, M., Valente, S., et al. 2014. Acute posterior multifocal placoid pigment epitheliopathy and neurological involvement in an elderly patient: Case report and review. Clin Ter, 165, 261–8. Italian.Google Scholar
Massé, H., Guyomard, J. L., Baudet, D., et al. 2009. Mitoxantrone therapy for acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis. Case Rep Med, 2009, 481512.Google Scholar
Matamala, J. M., Feuerhake, W., and Verdugo, R. 2013. Delayed recurrent stroke in a young patient with acute posterior multifocal placoid pigment epitheliopathy. J Stroke Cerebrovasc Dis, 22, e630–4.Google Scholar
Matsuo, T., Horikoshi, T., and Nagai, C. 2002. Acute posterior multifocal placoid pigment epitheliopathy and scleritis in a patient with pANCA-positive systemic vasculitis. Am J Ophthalmol, 133, 566–8.Google Scholar
Matsuo, T., Nakayama, T., Koyama, T., and Matsuo, N. 1987. Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica, 195, 97–102.Google Scholar
Misra, U. K., Jha, S., Kalita, J., and Sharma, K. 1996. Stroke: A rare presentation of Eales’ disease. A case report. Angiology, 47, 73–6.Google Scholar
O’Halloran, H. S., Pearson, P. A., Lee, W. B., Susac, J. O., and Berger, J. R. 1998. Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. Ophthalmology, 105, 1038–44.Google Scholar
O’Halloran, H. S., Berger, J. R., Lee, W. B., et al. 2001. Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: Nine new cases and a review of the literature. Ophthalmology, 108, 861–8.Google Scholar
Pagnoux, C., Thorne, C., Mandelcorn, E. D., and Carette, S. 2011. CNS involvement in acute posterior multifocal placoid pigment epitheliopathy. Can J Neurol Sci, 38, 526–8.Google Scholar
Park, D., Schatz, H., McDonald, H. R., and Johnson, R. N. 1995a. Acute multifocal posterior placoid pigment epitheliopathy: A theory of pathogenesis. Retina, 15, 351–2.Google Scholar
Park, D., Schatz, H., McDonald, H. R., and Johnson, R. N. 1995b. Indocyanine green angiography of acute multifocal posterior placoid pigment epitheliopathy. Ophthalmology, 102, 1877–83.Google Scholar
Parmeggiani, F., Costagliola, C., D’Angelo, S., et al. 2004. Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy. Oncology, 66, 502–9.Google Scholar
Poppenborg, M., Schabitz, W., Rauch, M., and Spital, G. 2011. Juvenile pontine infarction. Complication of acute posterior multifocal placoid pigment epitheliopathy. Nervenarzt, 82, 496, 498–9.Google Scholar
Priluck, I. A., Robertson, D. M., and Buettner, H. 1981. Acute posterior multifocal placoid pigment epitheliopathy. Urinary findings. Arch Ophthalmol, 99, 1560–2.CrossRefGoogle ScholarPubMed
Prokosch, V., Becker, H., Thanos, S., and Stupp, T. 2010. Acute posterior multifocal placoid pigment epitheliopathy with concurrent cerebral vasculitis and sarcoidosis. Graefes Arch Clin Exp Ophthalmol, 248, 151–2.Google Scholar
Reinthal, E. K., Schlote, T., and Zierhut, M. 2001. Neurological complications in acute posterior multifocal placoid pigment epitheliopathy (APMPPE): A review with case report. Klin Monatsbl Augenheilkd, 218, 756–62.Google Scholar
Roberts, T. V. and Mitchell, P. 1997. Acute posterior multifocal placoid pigment epitheliopathy: A long-term study. Aust N Z J Ophthalmol, 25, 277–81.Google Scholar
Ruiz Vinals, A. T., Buil Calvo, J. A., Martinez, G. O., and Castilla, C. M. 2002. Acute posterior multifocal placoid pigment epitheliopathy associated with Graves–Basedow’s disease. Arch Soc Esp Oftalmol, 77, 381–4.Google Scholar
Ryan, S. J. and Maumenee, A. E. 1972. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol, 74, 1066–74.Google Scholar
Savino, P. J., Weinberg, R. J., Yassin, J. G., and Pilkerton, A. R. 1974. Diverse manifestations of acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol, 77, 659–62.Google Scholar
Schubert, H. D., Lucier, A. C., and Bosley, T. M. 1988. Pigmentary epitheliopathy, disc edema, and lead intoxication. Retina, 8, 154–7.Google Scholar
Sigelman, J., Behrens, M., and Hilal, S. 1979. Acute posterior multifocal placoid pigment epitheliopathy associated with cerebral vasculitis and homonymous hemianopia. Am J Ophthalmol, 88, 919–24.Google Scholar
Smith, C. H., Savino, P. J., Beck, R. W., Schatz, N. J., and Sergott, R. C. 1983. Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. Arch Neurol, 40, 48–50.Google Scholar
Spaide, R. F., Yanuzzi, L. A., and Slakter, J. 1991. Choroidal vasculitis in acute posterior multifocal placoid pigment epitheliopathy. Br J Ophthalmol, 75, 685–7.Google Scholar
Stanga, P. E., Lim, J. I., and Hamilton, P. 2003. Indocyanine green angiography in chorioretinal diseases: Indications and interpretation. An evidence-based update. Ophthalmology, 110, 15–21.Google Scholar
Stoll, G., Reiners, K., Schwartz, A., et al. 1991. Acute posterior multifocal placoid pigment epitheliopathy with cerebral involvement. J Neurol Neurosurg Psychiatr, 54, 77–9.Google Scholar
Susac, J. O. 2004. Susac’s syndrome. AJNR Am J Neuroradiol, 25, 351–2.Google Scholar
Susac, J. O., Hardman, J. M., and Selhorst, J. B. 1979. Microangiopathy of the brain and retina. Neurology, 29, 313–6.Google Scholar
Susac, J. O., Murtagh, F. R., Egan, R. A., et al. 2003. MRI findings in Susac’s syndrome. Neurology, 61, 1783–7.Google Scholar
Suzuki, S., Mizota, A., and Chi-Usami, E. 2002. A case of hemophagocytic syndrome with retinal changes resembling acute posterior multifocal placoid pigment epitheliopathy. Retina, 22, 219–22.Google Scholar
Thomas, B. C., Jacobi, C., Korporal, M. et al. 2012. Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE). J Ophthalmic Inflamm Infect, 2, 125–31.Google Scholar
Thomson, S. P. and Roxburgh, S. T. 2003. Acute posterior multifocal placoid pigment epitheliopathy associated with adenovirus infection (letter). Eye, 17, 542–4.Google Scholar
Toenjes, W., Mielke, U., Schmidt, H. J., Haas, A., and Holzer, G. 1989. Akute multi-fokale plakoide Pigmentepitheliopathie mit entzuendlichem Liquorbefund. Sonderform einer Borreliose? Dtsch med Wschr, 114, 793–5.Google Scholar
Tsang, B. K., Chauhan, D. S., Haward, R., et al. 2014. Fatal ischemic stroke complicating acute multifocal placoid pigment epitheliopathy: Histopathological findings. J Neuroophthalmol, 34, 10–5.Google Scholar
Uthman, I., Najjar, D. M., Kanj, S. S., and Bashshur, Z. 2003. Anticardiolipin antibodies in acute multifocal posterior placoid pigment epitheliopathy. Ann Rheum Dis, 62, 687–8.Google Scholar
Uyama, M., Matsunaga, H., Matsubara, T., et al. 1999. Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy. Retina, 19, 12–21.Google Scholar
Van Buskirk, E. M., Lessell, S., and Friedman, E. 1971. Pigmentary epitheliopathy and erythema nodosum. Arch Ophthalmol, 85, 369–72.Google Scholar
Weinstein, J. M., Bresnik, G. H., Bell, C. L., et al. 1988. Acute posterior multifocal placoid pigment epitheliopathy associated with cerebral vasculitis. J Clin Neuroophthalmol, 8, 195–201.Google Scholar
Williams, D. F. and Mieler, W. F. 1989. Long-term follow-up of acute multifocal posterior placoid pigment epitheliopathy. Br J Ophthalmol, 73, 985–90.Google Scholar
Wilson, C. A., Choromokos, E. A., and Sheppard, R. 1988. Acute posterior multi-focal placoid pigment epitheliopathy and cerebral vasculitis. Arch Ophthalmol, 106, 796–800.CrossRefGoogle Scholar
Wolf, M. D., Folk, J. C., and Goeken, N. E. 1990a. Acute posterior multifocal pigment epitheliopathy and optic neuritis in a family. Am J Ophthalmol, 110, 89–90.Google Scholar
Wolf, M. D., Folk, J. C., Panknen, C. A., and Goeken, N. E. 1990b. HLA-B7 and HLA-DR2 antigens and acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol, 108, 698–700.Google Scholar
Wolf, M. D., Alward, W. L., and Folk, J. C. 1991. Long-term visual function in acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol, 109, 800–3.Google Scholar
Wright, B. E., Bird, A. C., and Hamilton, A. M. 1978. Placoid pigment epitheliopathy and Harada’s disease. Br J Ophthalmol, 62, 609–21.Google Scholar
Yang, D. S., Hilford, D. J., and Conrad, D. 2005. Acute posterior multifocal placoid pigment epitheliopathy after meningococcal C conjugate vaccine. Clin Experiment Ophthalmol, 33, 219–21.Google Scholar
Yunker, J. J., Ready, E. L, Tucker, C. L., Morris, R. E., and Witherspoon, C. D. 2008. Acute posterior multifocal placoid pigment epitheliopathy and thalamic infarction. Retin Cases Brief Rep, 2, 209–12.Google Scholar
Zuber, M., Blustajn, J., Arquizan, C., et al. 1999. Angiitis of the central nervous system. J Neuroradiol, 26, 101–17.Google Scholar

References

Allmendinger, A. M., Viswanadhan, N., Klufas, K. A., et al. 2013. Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome. J Neurol Sci, 333, 25–8.Google Scholar
Ballard, E., Butzer, J. F., and Donders, J. 1996. Susac’s syndrome: Neuropsychological characteristics in a young man. Neurology, 47, 266–8.Google Scholar
Bogousslavsky, J., Gaio, J. M., Caplan, L. R., et al. 1989. Encephalopathy, deafness and blindness in young women: A distinct retinocochleocerebral arteriolopathy? J Neurol Neurosurg Psychiatry, 52, 43.Google Scholar
Cafferty, M. S., Notis, C., and Kitei, R. 1994. Retinal artery occlusions, hearing loss and stroke in a 19-year old (abstract). Neurology, 44, A267.Google Scholar
Coppeto, J. R., Currie, J. N., Monteiro, M. L. R., and Lessell, S. 1984. A syndrome of arterial-occlusive retinopathy and encephalopathy. Am J Ophthalmol, 98, 189–202.Google Scholar
Cubillana, J. D., Soler, A., Albaladejo, I., et al. 2002. Sindrome de Susac como causa de hipoacusia neurosensorial. Acta Otorrinolaringol Esp, 53, 379–83.Google Scholar
Davidson, E., Tomlin, S., Hoffman, G. S., and Epstein, W. V. 1963. The levels of plasma coagulation factors after trauma and childbirth. J Clin Pathol, 16, 112.CrossRefGoogle ScholarPubMed
Delaney, W. V. and Torrisi, P. F. 1976. Occlusive retinal vascular disease and deafness. Am J Ophthalmol, 82, 232–6.Google Scholar
Dörr, P., Krautwald, S., Wildermann, B., et al. 2013. Characteristic of Susac syndrome: A review of all reported cases. Nat Rev Neurol, 9, 307–16.Google Scholar
Egan, R. A., Ha Nguyen, T., Gass, J. D., et al. 2003. Retinal arterial wall plaques in Susac syndrome. Am J Ophthalmol, 135, 483–6.Google Scholar
Egan, R. A., Hills, W. L., and Susac, J. O., et al. 2010. Gass plaques and fluorescein leakage in Susac syndrome. J Neurol Sci, 299, 97–100.Google Scholar
Feresiadou, A., Eriksson, U., Larsen, H. C., et al. 2014. Recurrence of Susac syndrome following 23 years of remission. Case Rep Neurol, 6, 171–5.Google Scholar
Flammer, J., Kaiser, H., and Haufschild, T. 2001. Susac syndrome: a vasospastic disorder? Eur J Ophthalmol, 11, 175–9.Google Scholar
Francis, H. W., Makary, C., Halpin, C., et al. 2011. Temporal bone in a case of Susac’s syndrome. Otol Neurotol, 32, 1198–204.Google Scholar
García-Carrasco, M., Jiménez-Hernández, C., Jiménez-Hernández, M., et al. 2011 Susac’s syndrome: An update. Autoinmun Rev, 10, 548–52.Google Scholar
García-Carrasco, M., Mendoza, P., and Cervera, C. 2014. Diagnosis and classification of Susac’s syndrome. Autoimmun Rev, 13, 347–50.Google Scholar
Gordon, D. L., Hayreh, S. S., and Adams, H. P. Jr. 1991. Microangiopathy of the brain, retina, and ear: Improvement without immunosuppressive therapy. Stroke, 22, 993–7.Google Scholar
Greco, A., De Virgilio, A., Gallo, A. et al. 2014. Susac’s syndrome: Pathogenesis, clinical variants and treatment approaches. Autoimmun Rev, 13, 814–21.Google Scholar
Gross, M. and Eliashar, R. 2005. Update on Susac’s syndrome. Curr Opin Neurol, 18, 311–4.CrossRefGoogle ScholarPubMed
Hardy, T. A., Garsia, R. J., Halmagyi, G. M., et al. 2011. Tumour necrosis factor (TNF) inhibitor therapy in Susac’s syndrome. J Neurol Sci, 302, 126–8.Google Scholar
Hardy, T. A., O’Brien, B., Gerbils, N., et al. 2014. Brain histopathology in three cases of Susac’s syndrome: Implications for lesion pathogenesis and treatment. J Neurol Neurosurg Psychiatry, 86, 583–4.Google Scholar
Heiskala, H., Somer, H., Kovanen, J., et al. 1988. Microangiopathy with encephalopathy, hearing loss and retinal arteriolar occlusions: Two new cases. J Neurol Sci, 86, 239–50.Google Scholar
Hua Le, H., Donlon, S. L., and Okuda, D. 2014. A case of Susac syndrome with cervical spinal cord involvement on MRI. J Neurol Sci, 337, 228–31.Google Scholar
Ioannides, Z.A., Airey, C., Fagermo, N., et al. 2013. Susac syndrome and multifocal motor neuropathy first manifesting in pregnancy. Aust N Z J Obstet Gynaecol, 53, 314–7.Google Scholar
Jarius, S., Neumayer, B., Wandinger, K.P., et al. 2009. Anti-endothelial serum antibodies in a patient with Susac’s syndrome. J Neurol Sci, 285, 259–61.CrossRefGoogle Scholar
Jarius, S., Kleffner, I., Dörr, J. M., et al. 2011. Clinical, paraclinical and serological findings in Susac syndrome: An international multicenter study. Neuroinflammation, 11, 46.Google Scholar
Kleffner, I., Deppe, M., Mohammadi, S., et al. 2008. Diffusion tensor imaging demonstrates fiber impairment in Susac syndrome. Neurology, 70, 1867–9.Google Scholar
Kleffner, I., Deppe, M., Mohammadi, S., et al. 2010. Neuroimaging in Susac’s syndrome: Focus on DTI. J Neurol Sci, 29, 92–6.Google Scholar
Kleffner, I., Duning, T., Lohmann, H., et al. 2012. A brief review of Susac syndrome. J Neurol Sci, 322, 35–40.Google Scholar
Lee., L. and Amezcua, L. 2009. Treatment of Susac’s syndrome with rituximab: A case report. Neurology, 72, 203.Google Scholar
Li, H. K., Dejean, B. J., and Tang, R. A. 1996. Reversal of visual loss with hyperbaric oxygen treatment in a patient with Susac syndrome. Ophthalmology, 103, 2091–8.Google Scholar
MacFadyen, D. J., Schneider, R. J., and Chisholm, I. A. 1987. A syndrome of brain, inner ear and retinal microangiopathy. Can J Neurol Sci, 14, 315–8.Google Scholar
Magro, C. M., Ross, P., Marsh, C. B., et al. 2007. The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease. Am J Clin Pathol, 127, 237–47.Google Scholar
Magro, C. M., Poe, J. C., Lubow, M., et al. 2011. Susac syndrome: An organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol, 136, 906–12.Google Scholar
Mala, L., Bazard, M. C., Berrod, J. P., Wahl, D., and Raspiller, A. 1998. Petits infarctus rétiniens, cochléaires et cérébraux du sujet jeune, ou “SICRET” syndrome ou syndrome de Susac. J Fr Ophthalmol, 21, 375–80.Google Scholar
Mass, M., Bourdette, D., Bernstein, W., and Hammerstad, J. 1988. Retinopathy, encephalopathy, deafness associated microangiopathy (the RED M syndrome): Three new cases. Neurology, 38, 215.Google Scholar
Mateen, F. J., Zubkov, A. Y., Muralidharan, R. et al. 2012. Susac syndrome: Clinical characteristics and treatment in 29 new cases. Eur J Neurol, 19, 800–11.Google Scholar
McCabe, B. F. 1979. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol, 88, 585–9.Google Scholar
Mike, A., Gaál, V., Németh, A., et al. 2007. Susac syndrome: Neurologic, psychiatric, ophthalmologic, otorhinolaryngologic and neuroradiologic, features of a rare autoimmune disease. Orv Hetil, 148, 897–905.Google Scholar
Monteiro, M. L. R., Swanson, R. A., Coppeto, J. R., et al. 1985. A microangiopathic syndrome of encephalopathy, hearing loss, and retinal arteriolar occlusions. Neurology, 35, 1113–21.Google Scholar
Narozny, W., Sicko, Z., Przewozny, T., et al. 2004. Usefulness of high doses of glucocorticoids and hyperbaric oxygen therapy in sudden sensorineural hearing loss treatment. Otol Neurotol, 25, 916–23.Google Scholar
Notis, C. M., Kitei, R. A., Cafferty, M. S., Odel, J. G., and Mitchell, J. P. 1995. Microangiopathy of brain, retina and inner ear. J Neurophthalmol, 15, 1–8.Google Scholar
Petty, G. W., Engel, A. G., Young, B. R., et al. 1998. Retinocochleocerebral vasculopathy. Medicine, 77, 12–40.Google Scholar
Petty, G. W., Matteson, E. L., Younge, B. R., McDonald, T. J., and Wood, C. P. 2001. Recurrence of Susac syndrome (retinocochleocerebral vasculopathy) after remission of 18 years. Mayo Clin Proc, 76, 958–60.Google Scholar
Pfaffenbach, D. D. and Hollenhorst, R. W. 1973. Microangiopathy of the retinal arterioles. JAMA, 225, 480–3.Google Scholar
Rennebohm, R. M., Egan, R. A., and Susac, J. O. 2008a. Treatment of Susac’s syndrome. Curr Treat Options Neurol, 10, 67–74.Google Scholar
Rennebohm, R. M., Lubow, M., Rusin, J., et al. 2008b. Aggresive immunosuppressive treatment of Susac’s syndrome in an adolescent: Using treatment of dermatomyositis as a model. Pediatr Rheumatol, 8, 3.Google Scholar
Rennebohm, R., Susac, J. O., Egan, R. A. et al. 2010. Susac’s syndrome: Update. J Neurol Sci, 299, 86–91.Google Scholar
Roeser, M. M., Driscoll, C. L., Shallop, J. K., et al. 2009. Susac syndrome: A report of cochlear implantation and review of otologic manifestations in twenty-three patients. Otol Neurotol, 30, 34–40.Google Scholar
Servettaz, A., Guilpain, A., Camoin, L., et al. 2008. Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach. Proteomics, 8, 1000–8.Google Scholar
Schwitter, J., Agosti, R., Ott, P., Kalman, A., and Waespe, W. 1992. Small infarctions of cochlear, retinal, and encephalic tissue in young women. Stroke, 23, 903–7.Google Scholar
Susac, J. O. 1994. Susac’s syndrome: The triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology, 44, 591–3.CrossRefGoogle ScholarPubMed
Susac, J. O., Hardman, J. M., and Selhorst, J. B. 1979. Microangiopathy of the brain and retina. Neurology, 29, 313–6.Google Scholar
Susac, J. O., Murtagh, F. R., Egan, R. A., et al. 2003. MRI findings in Susac’s syndrome. Neurology, 61, 1783–7.Google Scholar
Susac, J. O., Egan, R. A., Rennebohm, R. M., and Lubow, M. 2007. Susac’s syndrome: 1975–2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci, 257, 270–72.Google Scholar
Van der Kooij, S. M., Van Buchem, M. A., Overbeek, O. M., et al. 2015. Susac syndrome: A report of four cases and a review of the literature. Neth J Med, 73, 10–16.Google Scholar
Vodopivec, I., Venna, N., Rizzo, J. F., et al. 2015. Clinical features, diagnostic findings, and treatment of Susac syndrome: A case series. J Neurol Sci, 357, 50–7.Google Scholar
White, M. L., Zhang, Y., and Smoker, W. R. 2004. Evolution of lesions in Susac syndrome at serial MR imaging with diffusion-weighted imaging and apparent diffusion coefficient values. AJNR Am J Neuroradiol, 25, 706–13.Google Scholar
Wildemann, B., Schülin, C., Storch-Hagenlocher, B., et al. 1996. Susac’s syndrome: Improvement with combined antiplatelet and calcium antagonist therapy. Stroke, 1, 149–50.Google Scholar
Woolridge, D., Stefanelli, M., and Hoppe, B. 2006. Susac syndrome with frontal intermittent rhythmic delta activity (FIRDA). Can J Neurol Sci, 33, 403–6.Google Scholar
Wuertfer, J., Sinnecker, T., Ringelstein, E. B., et al. 2012. Lesiones morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler, 19, 1592–99.Google Scholar
Xu, M. S., Tan, C. B., Umapathi, T., and Lim, C. C. 2004. Susac syndrome: Serial diffusion-weighted MR imaging. Magn Reson Imaging, 22, 1295–8.Google Scholar

References

Cohen, A. C., Kotschet, K., Veitch, A., Delatycki, M. B., and McCombe, M. F. 2005. Novel ophthalmological features in hereditary endotheliopathy with retinopathy, nephropathy and stroke syndrome. Clin Experiment Ophthalmol, 33, 181–3.Google Scholar
Crow, Y. J., Hayward, B. E., Parmar, R., et al. 2006. Mutations in the gene encoding the 3’–5’ DNA exonuclease TREX1 cause Aicardi–Goutieres syndrome at the AGS1 locus. Nat Genet, 38, 917–20.Google Scholar
Grand, M. G., Kaie, J., Fulling, K., et al. 1988. Cerebroretinal vasculopathy, a new hereditary syndrome. Ophthalmology, 95, 649–59.Google Scholar
Gutmann, D. H., Fishbeck, K. H., and Sergott, R. C. 1989. Hereditary retinal vasculopathy with cerebral white matter lesions. Am J Med Genet, 34, 217–20.Google Scholar
Hasan, M., Fermaintt, C. S., Gao, N., et al. 2015. Cytosolic nuclease TREX1 regulates oligosaccharyl transferase activity independent of nuclease activity to suppress immune activation. Immunity, 43, 463–74.Google Scholar
Jen, J., Cohen, A. H., Yue, Q., et al. 1997. Hereditary endotheliopathy with retinopathy, nephropathy and stroke (HERNS). Neurology, 49, 1322–30.Google Scholar
Lee-Kirsch, M. A., Gong, M., Chowdhury, D., et al. 2007. Mutations in the gene encoding the 3’-5’ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet, 39, 1065–7.Google Scholar
Niedermayer, I., Graf, N., Schmidbauer, J., Reiche, W., and Feiden, W. 2000. Cerebroretinal vasculopathy mimicking a brain tumor. Neurology, 54, 1878–9.Google Scholar
Ophoff, R. A., DeYoung, J., Service, S. K., et al. 2001. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet, 69, 447–53.Google Scholar
Rice, G., Newman, W. G., Dean, J., et al. 2007. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi–Goutieres syndrome. Am J Hum Genet, 80, 811–5.Google Scholar
Richards, A., van den Maagdenberg, A. M., Jen, J. C., et al. 2007. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet, 39, 1068–70.Google Scholar
Terwindt, G. M., Haan, J., Ophoff, R. A., et al. 1998. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud’s phenomenon. Brain, 121, 303–16.Google Scholar

References

Albayram, M. S., Wityk, R., Yousem, D. M., and Zinreich, S. J. 2001. The cerebral angiographic findings in Cogan syndrome. AJNR Am J Neuroradiol, 22, 751–4.Google Scholar
Antonios, N., and Silliman, S. 2012. Cogan syndrome: An analysis of reported neurological manifestations. Neurologist, 18, 55–63.Google Scholar
Bicknell, J. M. and Holland, J. V. 1978. Neurologic manifestations of Cogan syndrome. Neurology, 28, 278–81.Google Scholar
Bonaguri, C., Orsoni, J., Russo, A., et al. 2014. Cogan’s syndrome: Anti-Hsp70 antibodies are a serological marker in the typical form. Isr Med Assoc J, 16, 285–8.Google Scholar
Calopa, M., Marti, T., Rubio, F., and Peres, J. 1991. Imagerie par résonance magnétique et syndrome de Cogan. Rev Neurol (Paris), 147, 161–3.Google Scholar
Casselman, J. W., Majoor, M. H., and Albers, F. W. 1994. MR of the inner ear in patients with Cogan syndrome. AJNR Am J Neuroradiol, 15, 131–8.Google Scholar
Cobo, L. M. and Haynes, B. F. 1984. Early corneal findings in Cogan’s syndrome. Ophthalmology, 91, 903–7.Google Scholar
Cogan, D. G. 1945. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol, 33, 144–9.Google Scholar
Fair, J. R. and Levi, G. A. 1960. Keratitis and deafness. Am J Ophthalmol, 49, 1017–21.CrossRefGoogle ScholarPubMed
Fricker, M., Baumann, A., Wermelinger, F., Villiger, P. M., and Helbling, A. 2007. A novel therapeutic option in Cogan diseases? TNF-alpha blockers. Rheumatol Int, 27, 493–5.Google Scholar
Gilbert, W. S. and Talbot, F. J. 1969. Cogan’s syndrome. Signs of periarteritis nodosa and cerebral venous sinus thrombosis. Arch Ophthalmol, 82, 633–6.Google Scholar
Gluth, M. B., Baratz, K. H., Matteson, E. L., and Driscoll, C. L. 2006. Cogan syndrome: A retrospective review of 60 patients throughout a half century. Mayo Clin Proc, 81, 483–8.Google Scholar
Grasland, A., Pouchot, J., Hachulla, E., et al., for the Study Group for Cogan’s syndrome. 2004. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology, 43, 1007–15.Google Scholar
Harris, J. P. and Sharp, P. A. 1990. Inner autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope, 100, 516–24.Google Scholar
Haynes, B. F., Kaiser-Kupfer, M. I., Mason, P., et al. 1980. Cogan syndrome: Studies in thirteen patients, long term follow-up, and a review of the literature. Medicine, 59, 426–41.Google Scholar
Helmchen, C., Jager, L., Buttner, U., Reiser, M., and Brandt, T. 1998. Cogan’s syndrome: High resolution MRI indicators of activity. J Vestib Res, 8, 155–67.Google Scholar
Helmchen, C., Arbusow, V., Jager, L., et al. 1999. Cogan’s syndrome: Clinical significance of antibodies against the inner ear and cornea. Acta Otolaryngol, 119, 528–36.Google Scholar
Karni, A., Sadeh, M., Blatt, I., and Goldhammer, Y. 1991. Cogan’s syndrome complicated by lacunar brain infarcts. J Neurol Neurosurg Psychiatry, 54, 169–71.Google Scholar
Kessel, A., Vadasz, Z., and Toubi, E. 2014. Cogan syndrome: Pathogenesis, clinical variants and treatment approaches. Autoimmun Rev, 13, 351–4.Google Scholar
Lunardi, C., Bason, C., Leandri, M., et al. 2002. Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet, 360, 915–21.Google Scholar
Majoor, M. H., Albers, F. W., van der Gaag, R., Gmelig-Meyling, F., and Huizing, E. H. 1992. Corneal autoimmunity in Cogan’s syndrome? Report of two cases. Ann Otol Rhinol Laryngol, 101, 679–84.Google Scholar
Manto, M. U., and Jacquy, J. 1996. Cerebellar ataxia in Cogan syndrome. J Neurol Sci, 136, 189–91.Google Scholar
McCabe, B. F. 1979. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol, 88, 585–9.Google Scholar
Norton, E. W. and Cogan, D. G. 1959. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms: Long-term follow-up. Arch Ophthalmol, 61, 695–7.Google Scholar
Orsoni, J. G., Zavota, L., Pellistri, I., Piazza, F., and Cimino, L. 2002. Cogan syndrome. Cornea, 21, 356–9.Google Scholar
Pasanisi, E., Vincenti, V., Bacciu, A., et al. 2003. Cochlear implantation and Cogan syndrome. Otol Neurotol, 24, 601–4.Google Scholar
Rabinovitch, J., Donnenfeld, E. D., and Laibson, P. R. 1986. Management of Cogan’s syndrome. Am J Ophthalmol, 101, 494–5.Google Scholar
Sigal, L. H. 1987. The neurologic presentation of vasculitic and rheumatologic syndromes. A review. Medicine, 66, 157–80.Google Scholar
Singer, O. 2015. Cogan and Behçet syndromes. Rheum Dis Clin North Am, 41, 75–91.Google Scholar
Vollertsen, R. S. 1990. Vasculitis and Cogan’s syndrome. Rheum Dis Clin North Am, 16, 433–8.Google Scholar
Vollertsen, R. S., McDonald, T. J., Younge, B. R., et al. 1986. Cogan’s syndrome: 18 cases and a review of the literature. Mayo Clin Proc, 61, 344–61.Google Scholar
Zeitouni, A. G., Tewfik, T. L., and Schloss, M. 1993. Cogan’s syndrome: A review of otologic management and 10-year follow-up of a pediatric case. J Otolaryngol, 22, 337–40.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×